Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00268593
Status:
COMPLETED
Last Update Posted:
2011-06-15
First Post:
2005-12-20
Brief Title:
Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer
Sponsor:
Progen Pharmaceuticals
Organization:
Progen Pharmaceuticals
Organization Data
Organization:
Progen Pharmaceuticals
Class:
INDUSTRY
Study ID:
PR88206
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Progen Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Darryn Bampton
Old Organization:
Progen Pharmaceuticals
Collaborators
| Name | Class |
|---|---|
| Aventis Pharmaceuticals | INDUSTRY |
| Northern Sydney and Central Coast Area Health Service | OTHER |